BioCentury | Dec 14, 2015
Strategy

Networking in Japan

...the JV for $150 million in cash and debt. Teva also acquired Japanese generics company Taiyo Pharmaceutical Industry Co. Ltd....
BioCentury | Jan 16, 2012
Strategy

Rebooting confidence

...a German generics and biosimilars company; and the addition last year of Japanese generics company Taiyo Pharmaceutical Industry Co. Ltd....
BioCentury | Jul 18, 2011
Company News

Teva, Taiyo deal

...Teva completed its previously announced acquisition of Taiyo, acquiring 100% of the generics company for $934...
...hand and debt (see BioCentury, May 23). Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA), Petah Tikva, Israel Taiyo Pharmaceutical Industry Co. Ltd....
BioCentury | May 23, 2011
Company News

Teva, Taiyo deal

...Teva will acquire 57% of Japanese generics company Taiyo for $460 million in cash. Teva also...
...acquire the remaining outstanding shares of Taiyo in a deal that Teva said would give Taiyo...
...in a deal that Teva said would give Taiyo an enterprise value of $1.3 billion. Taiyo...
BioCentury | May 23, 2011
Finance

Highlights of weekly biotech stock moves

...$0.20 to $49.87 last week after announcing it will acquire 57% of Japanese generics company Taiyo Pharmaceutical Industry Co. Ltd....
...offer to acquire the remaining outstanding shares in a deal that it said would give Taiyo...
BioCentury | May 17, 2011
Company News

Teva to acquire majority stake in Taiyo

...Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) will acquire 57% of Japanese generics company Taiyo Pharmaceutical Industry Co. Ltd. (Nagoya, Japan) for...
...acquire the remaining outstanding shares of Taiyo in a deal that Teva said would give Taiyo...
...in a deal that Teva said would give Taiyo an enterprise value of $1.3 billion. Taiyo...
Items per page:
1 - 6 of 6
BioCentury | Dec 14, 2015
Strategy

Networking in Japan

...the JV for $150 million in cash and debt. Teva also acquired Japanese generics company Taiyo Pharmaceutical Industry Co. Ltd....
BioCentury | Jan 16, 2012
Strategy

Rebooting confidence

...a German generics and biosimilars company; and the addition last year of Japanese generics company Taiyo Pharmaceutical Industry Co. Ltd....
BioCentury | Jul 18, 2011
Company News

Teva, Taiyo deal

...Teva completed its previously announced acquisition of Taiyo, acquiring 100% of the generics company for $934...
...hand and debt (see BioCentury, May 23). Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA), Petah Tikva, Israel Taiyo Pharmaceutical Industry Co. Ltd....
BioCentury | May 23, 2011
Company News

Teva, Taiyo deal

...Teva will acquire 57% of Japanese generics company Taiyo for $460 million in cash. Teva also...
...acquire the remaining outstanding shares of Taiyo in a deal that Teva said would give Taiyo...
...in a deal that Teva said would give Taiyo an enterprise value of $1.3 billion. Taiyo...
BioCentury | May 23, 2011
Finance

Highlights of weekly biotech stock moves

...$0.20 to $49.87 last week after announcing it will acquire 57% of Japanese generics company Taiyo Pharmaceutical Industry Co. Ltd....
...offer to acquire the remaining outstanding shares in a deal that it said would give Taiyo...
BioCentury | May 17, 2011
Company News

Teva to acquire majority stake in Taiyo

...Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) will acquire 57% of Japanese generics company Taiyo Pharmaceutical Industry Co. Ltd. (Nagoya, Japan) for...
...acquire the remaining outstanding shares of Taiyo in a deal that Teva said would give Taiyo...
...in a deal that Teva said would give Taiyo an enterprise value of $1.3 billion. Taiyo...
Items per page:
1 - 6 of 6